Dr. Stanton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Joslin Pl
Renal Section, Joslin Diabetes Center
Boston, MA 02215Phone+1 617-309-2477Fax+1 617-309-2467
Summary
- Robert C. Stanton, MD is a highly accomplished nephrologist affiliated with Joslin Diabetes Center and Beth Israel Deaconess Medical Center in Boston, Massachusetts. He is the Chief of the Kidney and Hypertension Section at Joslin Diabetes Center.
Specialties and Clinical Interests:
Internal Medicine-Nephrology
Diabetic Nephropathy
Fluid, Acid-Base and Electrolyte Disorders
General Nephrology
Hypertension
Education and Training:
Medical Education: Hahnemann University School of Medicine
Residency: Oregon Health & Science University Hospital
Fellowships: Brigham & Women's Hospital and Tufts Medical Center
Academic Appointments:
Associate Professor of Medicine at Harvard Medical School
Research Focus:
Dr. Stanton's research primarily focuses on glucose 6-phosphate dehydrogenase (G6PD), an essential enzyme that plays a major role in regulating oxidative stress levels in cells. His work aims to understand the basic cellular mechanisms responsible for diabetic kidney disease, pancreatic beta cell death, and cardiovascular disease in people with diabetes. His research has led to new understanding of the central role of G6PD in normal physiology and pathophysiology.
Clinical Practice:
He provides care for patients with various kidney diseases, diabetes-related kidney issues, and hypertension.
Teaching and Recognition:
Dr. Stanton is actively involved in teaching at all levels, from students to faculty, and is routinely invited to lecture both nationally and internationally. He has received three Honorary Professorships from universities in China. Dr. Stanton has also been recognized as a Top Doctor by Boston Magazine for multiple years and has received an Award for Sustained Excellence in Teaching from Harvard Medical School.
Dr. Stanton's work combines clinical care, research, and education, making him a prominent figure in the field of nephrology, particularly in relation to diabetes-related kidney complications.
Education & Training
- Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1984 - 1987
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1980 - 1984
- Drexel University College of MedicineClass of 1980
Certifications & Licensure
- FL State Medical License 2021 - Present
- MA State Medical License 1984 - 2025
- OR State Medical License 1981 - 1985
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 140 citations5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2023.Nuha A ElSayed, Grazia Aleppo, Vanita R Aroda, Raveendhara R Bannuru, Florence M Brown
Diabetes Care. 2023-01-01 - 70 citations13. Older Adults: Standards of Care in Diabetes-2023.Nuha A ElSayed, Grazia Aleppo, Vanita R Aroda, Raveendhara R Bannuru, Florence M Brown
Diabetes Care. 2023-01-01 - 63 citations14. Children and Adolescents: Standards of Care in Diabetes-2023.Nuha A ElSayed, Grazia Aleppo, Vanita R Aroda, Raveendhara R Bannuru, Florence M Brown
Diabetes Care. 2023-01-01
Journal Articles
- Recruitment and food-retrieving behavior in Novomessor (Formicidae, Hymenoptera)Holldobler B, Stanton R, Markl H, Behavioral Ecology and Sociobiology 4:163-181, 1978
- A New Exocrine Gland in Novomessor (Hymenoptera:Formicidae) and its Possible Signficance as a Taxonomic CharacterHolldobler B, Stanton R, Engel H., Psyche 83:32-41, 1976
Press Mentions
- No Agreement on Antioxidant Use for Cardiovascular Risk in CKDAugust 13th, 2024
- Study Suggests Ways DPP-4 Inhibitor Might Prevent Kidney DiseaseJuly 23rd, 2018
- New Agents, Novel Targets Show Promise for Diabetic Kidney DiseaseMay 15th, 2017
Grant Support
- Glucose 6-P Dehydrogenase And Diabetic ComplicationsNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2008
- Glucose 6-P Dehydrogenase In Diabetic ComplicationsNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: